There were 2 new imported cases and 1 new asymptomatic infection case reported in Tianjin as of 7th of October.

The 104th imported case is a 31-year-old Chinese man who lived in Niamey, Niger. The patient arrived at Tianjin Binhai International Airport on October 2 by connecting flight (AF202) from Niamey to Paris, France.

The 105th imported case is a 53-year-old Chinese woman who lived in Madrid, Spain. The patient took flight from Madrid, Spain, and arrived at Tianjin Binhai International Airport on October 4th.

The 64th asymptomatic infection case is a 26-year-old Chinese staff who lived in the Republic of Congo. The patient took flight from Brazzaville, Republic of Congo, and arrived at Tianjin Binhai International Airport on October 4th.

So far, of all the 105 imported cases, 101 patients have been discharged upon recovery. 4 patients still hospitalized.

-No imported suspected cases are undergoing test.
-No new locally transmitted cases or suspected cases were reported.
-4 asymptomatic infection cases are undergoing medical observation right now

天津新增2境外输入病例！新增1例境外输入无症状感染者！

10月4日18时至5日18时，我市新增境外输入新冠肺炎确诊病例2例（中国籍），累计报告105例（中国籍93例、美国籍3例、菲律宾籍7例、法国籍1例、乌兹别克斯坦籍1例），治愈出院101例，在院4例（其中轻型2例，普通型2例）。

第104例境外输入确诊病例，男，31岁，中国籍，近期居住地尼日尔尼亚美。该患者由尼亚美经法国巴黎转乘航班（AF202）于10月2日抵达天津滨海国际机场，入境时体温36.5℃，申报无症状。经海关检疫排查采样后，即转送至河北区集中隔离医学观察点。当日海关实验室新冠病毒核酸检测结果为阳性，即由120救护车转送至空港医院发热门诊就诊。经市专家组确诊为我市第63例无症状感染者，在空港医院进行隔离医学观察。入院后，患者出现发热伴咽部不适，2次测体温均为37.4℃。经市级专家组综合分析确定为我市境外输入新冠肺炎确诊病例（轻型）。即转至海河医院治疗。全程实施闭环管理。

第105例境外输入确诊病例，女，53岁，中国籍，近期居住地西班牙马德里。该患者由西班牙马德里乘航班（CA908）于10月4日抵达天津滨海国际机场，入境时体温36.4℃，申报无症状。经海关检疫排查采样后，即转送至和平区集中隔离医学观察点。当日海关实验室新冠病毒核酸检测结果为阳性，即由120救护车转送至空港医院发热门诊就诊，胸CT示右肺胸膜下区浅淡磨玻璃密度影。5日经市级专家组综合分析确定为我市境外输入新冠肺炎确诊病例（普通型），即转至海河医院治疗。全程实施闭环管理。

第64例无症状感染者，女，26岁，企业员工，中国籍，近期居住地刚果共和国。该患者由刚果共和国布拉柴维尔乘航班（MF8010）于10月4日抵达天津滨海国际机场，入境时体温36.5℃，申报无症状。经海关检疫排查采样后，即转送至蓟州区集中隔离医学观察点。5日海关实验室新冠病毒核酸检测结果为阳性，即由120救护车转送至空港医院发热门诊就诊。经市专家组确诊为我市无症状感染者，继续在空港医院进行隔离医学观察。全程实施闭环管理。

Comments (0)

Name

Email

Title

Comment

smaller | bigger

Subscribe via email (Registered users only)

I have read and agree to the Terms of Usage.

Write the displayed characters

Add Comment